Matthew Stanton
Stock Analyst at Jefferies
(0.19)
# 4,083
Out of 4,829 analysts
5
Total ratings
33.33%
Success rate
-38.22%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $7.07 | +13.15% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $1.07 | +203.74% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $23.29 | -5.54% | 1 | Apr 4, 2024 | |
| AZTA Azenta | Initiates: Hold | $64 | $26.79 | +138.90% | 1 | Apr 4, 2024 |
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $7.07
Upside: +13.15%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $1.07
Upside: +203.74%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $23.29
Upside: -5.54%
Azenta
Apr 4, 2024
Initiates: Hold
Price Target: $64
Current: $26.79
Upside: +138.90%